| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4258303 | Transplantation Proceedings | 2011 | 4 Pages |
Abstract
The mTOR immunosuppressive drugs are safe for liver transplant patients, effectively controlling renal dysfunction. They can be used in other indications, such as neurotoxicity, de novo tumors, and high risk of HCC recurrence. More studies are needed to clarify their long-term effectiveness.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
G. Sanchez AntolÃn, F. Garcia Pajares, S. Lorenzo Pelayo, M.T. Herranz Bachiller, C. Almohalla, R. Velicia, A. Caro Paton,